Paper214818
Captopril (SQ 14,225) (D-3-mercapto-2-methylpropranoyl-L-proline): a novel orally active inhibitor of angiotensin-converting enzyme and antihypertensive agent.
Rubin B and 2 others. Prog Cardiovasc Dis, 1978. Cited by 114 papers, by iCite.
Cite this record
ConductScience Library. Captopril (SQ 14,225) (D-3-mercapto-2-methylpropranoyl-L-proline): a novel orally active inhibitor of angiotensin-converting enzyme and antihypertensive agent. Papers, record 214818. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/214818
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Captopril (SQ 14,225) (D-3-mercapto-2-methylpropranoyl-L-proline): a novel orally active inhibitor of angiotensin-converting enzyme and antihypertensive agent.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Angiotensin-Converting Enzyme Inhibitors | Major topic |
| Antihypertensive Agents | Major topic |
| Hypertension | Major topic |
| Proline | Major topic |
| Acute Disease | |
| Animals | |
| Blood Pressure | |
| Cats | |
| Chronic Disease | |
| Dogs | |
| Guinea Pigs | |
| Haplorhini | |
| Hypertension, Renal | |
| Ileum | |
| Macaca mulatta | |
| Male | |
| Muscle Contraction | |
| Rats | |
| Teprotide |
Source PubMed
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 114 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42506706 | Animal Venoms Targeting Cellular Mechanisms: Advances and Implications for Drug Discovery and Disease Therapy. | Toxins (Basel) | 2026 | https://conductscience.org/library/papers/42506706 | PubMed |
| 28510941 | Vasorelaxing and antihypertensive activities of synthesized peptides derived from computer-aided simulation of pepsin hydrolysis of yam dioscorin. | Bot Stud | 2014 | https://conductscience.org/library/papers/28510941 | PubMed |
| 20714908 | Captopril potentiates the anticonvulsant activity of carbamazepine and lamotrigine in the mouse maximal electroshock seizure model. | J Neural Transm (Vienna) | 2010 | https://conductscience.org/library/papers/20714908 | PubMed |
| 7470759 | A comparison of the ability of two angiotensin II receptor blocking drugs, 1-Sar; 8-Ala angiotensin II and 1-Sar, 8-Ile angiotensin II, to modify the regulation of glomerular filtration rate in the cat. | Br J Pharmacol | 1980 | https://conductscience.org/library/papers/7470759 | PubMed |
| 7049203 | Captopril as treatment for patients with pulmonary hypertension. Problem of variability in assessing chronic drug treatment. | Br Heart J | 1982 | https://conductscience.org/library/papers/7049203 | PubMed |
| 7033500 | The renin-angiotensin system in drinking and cardiovascular responses to isoprenaline in the rat. | J Physiol | 1981 | https://conductscience.org/library/papers/7033500 | PubMed |
| 6993550 | The involvement of arachidonic acid metabolism in the control of renin release. | J Endocrinol Invest | 1980 | https://conductscience.org/library/papers/6993550 | PubMed |
| 6986949 | Effects of an angiotensin-converting enzyme inhibitor (captopril) on blood pressure in anephric subjects. | Br Med J | 1980 | https://conductscience.org/library/papers/6986949 | PubMed |
| 6753911 | Racial differences in response to low-dose captopril are abolished by the addition of hydrochlorothiazide. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/6753911 | PubMed |
| 6597352 | The effect of kinins on paw oedema and uterus in rats. | Naunyn Schmiedebergs Arch Pharmacol | 1984 | https://conductscience.org/library/papers/6597352 | PubMed |
| 6325675 | Increased or decreased thirst caused by inhibition of angiotensin-converting enzyme in the rat. | J Physiol | 1984 | https://conductscience.org/library/papers/6325675 | PubMed |
| 6282931 | Inhibition of vascular permeability changes in rats by captopril. | J Clin Invest | 1982 | https://conductscience.org/library/papers/6282931 | PubMed |
| 6175193 | The effect of captopril on plasma histamine and histamine release in vitro. | Agents Actions | 1981 | https://conductscience.org/library/papers/6175193 | PubMed |
| 3023783 | Adverse reactions with angiotensin converting enzyme (ACE) inhibitors. | Med Toxicol | 1986 | https://conductscience.org/library/papers/3023783 | PubMed |
| 2682132 | Angiotensin-converting enzyme inhibitors and their influence on inflammation, bronchial reactivity and cough. A research review. | Med Toxicol Adverse Drug Exp | 1989 | https://conductscience.org/library/papers/2682132 | PubMed |
| 1697196 | Angiotensin converting enzyme inhibitors potentiate the bronchoconstriction induced by substance P in the guinea-pig. | Br J Pharmacol | 1990 | https://conductscience.org/library/papers/1697196 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ACE | 1636 | PubTator's text mining | https://conductscience.org/library/genes/1636 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/214818
GET https://conductscience.org/api/papers/v1/214818/authors